WELLS FARGO & COMPANY/MN
Position in ATNM — Actinium Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in ATNM
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$19,700
-$7,228 QoQ
Shares Held
19,800
0.0% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATNM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. ATNM ranks #270 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in ATNM
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,700 | 19,800 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $26,928 | 19,800 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $31,680 | 19,800 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,711 | 5,508 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $32,724 | 20,326 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $25,192 | 19,994 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $27,370 | 14,559 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $110,437 | 14,924 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $107,012 | 13,667 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $63,210 | 12,443 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $63,385 | 10,707 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $119,469 | 16,101 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $51,748 | 5,476 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $58,276 | 5,472 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $37,394 | 5,067 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,333 | 5,059 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $25,733 | 5,036 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $30,260 | 5,035 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $48,817 | 5,510 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $12,252 | 1,549 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $10,469 | 1,374 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $135,562 | 17,380 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $5,513 | 569 | Shares | Defined | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||